Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novartis Announces NEJM Publication Of Secukinumab Phase III Data Confirming Significant Efficacy In Patients With Psoriatic Arthritis

By: via Benzinga
Novartis International AG / Novartis announces NEJM publication of secukinumab Phase III data confirming significant efficacy in ...
Related Stocks:
Novartis Ag ADR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.